Tyra Biosciences Inc Financial Flexibility Index
Tyra Biosciences Inc financial flexibility index. Tyra Biosciences Inc (TYRA) has a Financial Flexibility Index of -1.01x as of December 2025. Free cash flow of $-23.57 Million (operating CF $-23.62 Million minus capex $57.00K) represents -1% of total liabilities ($23.43 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Tyra Biosciences Inc (2019–2025)
Financial flexibility index of Tyra Biosciences Inc from 2019 to 2025. Historical Financial Flexibility Index trend for Tyra Biosciences Inc across 7 annual periods. Explore Tyra Biosciences Inc (TYRA) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Tyra Biosciences Inc Financial Flexibility Index by Year (2019–2025)
Tyra Biosciences Inc financial flexibility index by year from 2019 to 2025. Year-by-year free cash flow to debt coverage for Tyra Biosciences Inc. For the full cash flow conversion analysis, see TYRA cash flow metrics.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -4.05x | $-95.00 Million | $-95.14 Million | $23.43 Million | ▼ -19.7% |
| 2024 | -3.39x | $-69.11 Million | $-69.77 Million | $20.41 Million | ▼ -48.1% |
| 2023 | -2.29x | $-49.37 Million | $-50.14 Million | $21.59 Million | ▲ +61.6% |
| 2022 | -5.95x | $-49.73 Million | $-50.28 Million | $8.35 Million | ▼ -28.0% |
| 2021 | -4.65x | $-23.08 Million | $-23.75 Million | $4.96 Million | ▼ -1750.4% |
| 2020 | -0.25x | $-7.45 Million | $-7.76 Million | $29.65 Million | ▲ +49.0% |
| 2019 | -0.49x | $-2.60 Million | $-2.62 Million | $5.27 Million | — |